APEX™
Our flagship. Two integrated reports for hormone therapy: APEX Gene™ settles the safe estrogen route once, before the first prescription, and APEX™ tracks how each patient actually metabolises estrogen over time.
Novlogics turns biomarker data into evidence-graded clinical intelligence. Traceable, transparent, built to sharpen the judgment of the clinician who signs it off.
Progesterone opposition low against estradiol. Estrogen metabolism favours the protective 2-OH pathway.
Each addresses a different clinical domain. All hold identical epistemic standards: graded evidence, visible reasoning, mandatory sign-off.
Our flagship. Two integrated reports for hormone therapy: APEX Gene™ settles the safe estrogen route once, before the first prescription, and APEX™ tracks how each patient actually metabolises estrogen over time.
Three plasma biomarkers for Alzheimer-type pathology, read for concordance under the 2024 AA criteria. It calls borderline borderline, and tells you when to confirm with PET or CSF.
Learn moreA 41-analyte amino acid panel. Metabolic pathway mapping, pattern detection and structured clinical intelligence for functional and integrative practice.
Learn moreA straightforward path that fits existing clinical workflows, transparent at every step.
Select the CDSS product in the clinician portal. Provide pseudonymised identifiers and clinical context.
Upload validated laboratory values. The system accepts standardised panel formats from major laboratory networks.
The engine reads values against evidence-graded reference ranges, derives ratios, and assembles structured intelligence.
Every recommendation arrives with its full reasoning, evidence grade and source citation. Licensed HCP sign-off required.
Every Novlogics report shows every step of its reasoning in full: the formula, the input values, the evidence grade, the source citation. If we cannot show the reasoning, we do not present the conclusion.
Every report requires licensed HCP review and sign-off. The clinician bears sole responsibility for the clinical decision.
We distinguish Grade A trial evidence from expert consensus, and we say which is which. Overstating the evidence base is a form of harm we refuse to commit.
HIPAA, GDPR Article 9 and the EU AI Act high-risk provisions are the baseline for every deployment, not optional extras.
Request a demonstration of APEX™, CASCADE™ or AminoLogic. Download sample reports. No commitment required.